Cardiovascular disease in patients with schizophrenia

@article{Kritharides2017CardiovascularDI,
  title={Cardiovascular disease in patients with schizophrenia},
  author={L. Kritharides and V. Chow and T. Lambert},
  journal={Medical Journal of Australia},
  year={2017},
  volume={206}
}
Patients with schizophrenia die on average 25 years earlier than the general population, and this gap appears to be increasing. Most of the excess mortality is due to premature cardiovascular deaths rather than suicide. Many psychotropic agents are orexigenic and can increase weight and promote dyslipidaemia. Traditional cardiac risk factors are undertreated among patients with schizophrenia, and they are less likely to receive cardiac revascularisation than those without a mental illness… Expand
26 Citations
Cardiovascular disease in patients with schizophrenia
  • 4
Cardiovascular disease in patients with schizophrenia
  • D. Skalicky
  • Medicine
  • The Medical journal of Australia
  • 2017
Direct and indirect effects of psychopharmacological treatment on the cardiovascular system
  • K. Kahl
  • Medicine
  • Hormone molecular biology and clinical investigation
  • 2018
  • 7
Dimensions of improvement: The physical health of people with mental illness
  • 2
  • Highly Influenced
...
1
2
3
...

References

SHOWING 1-10 OF 70 REFERENCES
Twenty-five year mortality of a community cohort with schizophrenia
  • 474
  • PDF
...
1
2
3
4
5
...